Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|October 21, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the USErin Mulvey, Jason Shafrin, Kyi-Sin Than, et al.
Oncoimmunology|July 8, 2026
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphomaLorenzo Falchi, Martin Hutchings, David Tybor, et al.
Journal of Hematology & Oncology|August 16, 2024
Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphomaAllison Rosenthal, Javier Munoz, Monika Jun, et al.
Future Oncology (London, England)|August 13, 2025
Clinical representativeness of pivotal trials for T-cell engagers in relapsed/refractory follicular lymphomaZhijie Ding, Guihua Zhang, Junhua Yu, et al.
Blood Advances|June 5, 2025
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphomaAlexey V Danilov, Swetha Kambhampati Thiruvengadam, Kim Linton, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
A Human Tumor-Immune Organoid Model of GlioblastomaShivani Baisiwala, Elisa Fazzari, Matthew X Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2025
Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative AnalysisJavier Munoz, Allison Rosenthal, Andrew Ip, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
α-Synuclein Strain Dynamics Correlate with Cognitive Shifts in Parkinson's DiseaseKundlik Gadhave, Enquan Xu, Ning Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and ActivationTom B Davidson, Alexander Lee, Melody Hsu, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Pathological Tau transmission initiated by binding lymphocyte-activation gene 3Chan Chen, Ramhari Kumbhar, Hu Wang, et al.
Pageof 6